BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18447715)

  • 1. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
    Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
    J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.
    Sheehan J; Sherman J; Cifarelli C; Jagannathan J; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2009 Aug; 111(2):226-9. PubMed ID: 19326986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
    Gainer JL; Sheehan JP; Larner JM; Jones DR
    J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.
    Sheehan JP; Popp B; Monteith S; Toulmin S; Tomlinson J; Martin J; Cifarelli CP; Lee DH; Park DM
    J Neurosurg; 2011 Oct; 115(4):749-53. PubMed ID: 21682571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
    Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS
    PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery.
    Sheehan JP; Xu Z; Popp B; Kowalski L; Schlesinger D
    J Neurosurg; 2013 Apr; 118(4):830-7. PubMed ID: 23198803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo.
    Shankar A; Kumar S; Iskander AS; Varma NR; Janic B; deCarvalho A; Mikkelsen T; Frank JA; Ali MM; Knight RA; Brown S; Arbab AS
    Chin J Cancer; 2014 Mar; 33(3):148-58. PubMed ID: 24016393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.
    Wang Y; Yoshimura R; Manabe H; Schretter C; Clarke R; Cai Y; Fitzgerald M; Lee KS
    Brain Res; 2014 Oct; 1583():245-54. PubMed ID: 25128603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
    Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation.
    Okonkwo DO; Wagner J; Melon DE; Alden T; Stone JR; Helm GA; Jane JA
    Neurosci Lett; 2003 Dec; 352(2):97-100. PubMed ID: 14625032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme.
    Lee DY; Chunta JL; Park SS; Huang J; Martinez AA; Grills IS; Krueger SA; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):978-85. PubMed ID: 23845846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts.
    Kinsella TJ; Kinsella MT; Seo Y; Berk G
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1254-61. PubMed ID: 17967315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver nanoparticles: a novel radiation sensitizer for glioma?
    Liu P; Huang Z; Chen Z; Xu R; Wu H; Zang F; Wang C; Gu N
    Nanoscale; 2013 Dec; 5(23):11829-36. PubMed ID: 24126539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
    Shieh LT; Guo HR; Ho CH; Lin LC; Chang CH; Ho SY
    PLoS One; 2020; 15(5):e0233188. PubMed ID: 32413077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.